SBI Securities’s Rein Therapeutics RNTX Stock Holding History

SBI Securities’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$402	Buy	+500	New	+$410	﹤0.01%	3186

Other funds holding RNTX

Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Gleason Group Prospect, Kentucky $1.13B AUM 12.68% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Cane Capital Partners Saint Francisville, Louisiana $269M AUM 28.65% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

SBI Securities's RNTX Position: Q3 2026 in Review

SBI Securities opened a new position in Rein Therapeutics (RNTX) in Q3 2026: 500 shares worth $402. The stake represents ﹤0.01% of the portfolio and ranks #3186 among its holdings.

9 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.

SBI Securities held 500 shares of Rein Therapeutics worth $402 as of Q3 2026.
Rein Therapeutics was a new SBI Securities position in Q3 2026.
Rein Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3186 holding.
9 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.